CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,837,566
- in 4 filings, $626K under 10b5-1 plans
Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-14 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 181,163 | ||
| 2015-12-22 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +746 | $0.98 | $731 | 139,172 |
| 2015-12-22 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −746 | $15.00 | $11K | 138,426 |
| 2015-12-22 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −746 | 143,200 | ||
| 2015-12-19 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +7,300 | $4.10 | $30K | 138,426 |
| 2015-12-19 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −7,300 | 112,700 | ||
| 2015-12-18 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +15,154 | $0.98 | $15K | 146,280 |
| 2015-12-18 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −15,154 | $15.00 | $227K | 131,126 |
| 2015-12-18 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −15,154 | 143,946 | ||
| 2015-11-23 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +15,900 | $0.98 | $16K | 147,026 |
| 2015-11-23 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −15,900 | $15.00 | $239K | 131,126 |
| 2015-11-23 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −15,900 | 159,100 | ||
| 2015-11-18 | Cable Thomas J. Director | Sale | −2,000 | $13.73 | $27K | 51,067 |
| 2015-09-04 | Demopulos Peter A MD Director | Purchase | +3,962 | $12.68 | $50K | 185,182 |
| 2015-08-18 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +12,000 | $0.98 | $12K | 1,603,822 |
| 2015-08-18 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −12,000 | 281,163 | ||
| 2015-07-15 | Cable Thomas J. Director | Sale | −2,000 | $18.78 | $38K | 53,067 |
| 2015-07-07 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +5,102 | $2.45 | $12K | 131,126 |
| 2015-07-07 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −5,102 | 0 | ||
| 2015-06-14 | Shah Rajiv Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 19 of 20 · 391 trades